HEADER HYDROLASE 27-FEB-03 1ONH TITLE GC1 BETA-LACTAMASE WITH A PENEM INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CLASS C BETA-LACTAMASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTER CLOACAE; SOURCE 3 ORGANISM_TAXID: 550; SOURCE 4 GENE: BLAC; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: AS226-51; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PCS101 KEYWDS MIXED ALPHA/BETA, CEPHALOSPORINASE, INHIBITION, CLASS C BETA- KEYWDS 2 LACTAMASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.NUKAGA,K.NUKAGA,J.R.KNOX REVDAT 5 16-AUG-23 1ONH 1 REMARK REVDAT 4 24-JUL-19 1ONH 1 REMARK LINK REVDAT 3 13-JUL-11 1ONH 1 VERSN REVDAT 2 24-FEB-09 1ONH 1 VERSN REVDAT 1 09-DEC-03 1ONH 0 JRNL AUTH M.NUKAGA,T.ABE,A.M.VENKATESAN,T.S.MANSOUR,R.A.BONOMO, JRNL AUTH 2 J.R.KNOX JRNL TITL INHIBITION OF CLASS A AND CLASS C BETA-LACTAMASES BY PENEMS: JRNL TITL 2 CRYSTALLOGRAPHIC STRUCTURES OF A NOVEL 1,4-THIAZEPINE JRNL TITL 3 INTERMEDIATE JRNL REF BIOCHEMISTRY V. 42 13152 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 14609325 JRNL DOI 10.1021/BI034986B REMARK 2 REMARK 2 RESOLUTION. 1.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.138 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.135 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 3.200 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2063 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 65596 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.121 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.118 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.178 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 3.200 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1638 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 53011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2767 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 427 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3219.6 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2680.9 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 36 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 30398 REMARK 3 NUMBER OF RESTRAINTS : 38104 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : 0.028 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.060 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.069 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.015 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.003 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.053 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.094 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ONH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAR-03. REMARK 100 THE DEPOSITION ID IS D_1000018471. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9474 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65047 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.380 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.52 REMARK 200 R MERGE FOR SHELL (I) : 0.51400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1GCE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 8000 IN 50 MM HEPES OVER 20 % REMARK 280 PEG, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 38.14400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.43650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.14400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.43650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 503 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 504 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 133 NE CZ NH1 NH2 REMARK 470 LYS A 180 CE NZ REMARK 470 LYS A 183 CE NZ REMARK 470 GLU A 196 CD OE1 OE2 REMARK 470 LYS A 207 NZ REMARK 470 LYS A 293 CD CE NZ REMARK 470 LYS A 312 CE NZ REMARK 470 LYS A 335 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 64 O8 WY4 A 400 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 34 CG - CD2 - CE2 ANGL. DEV. = -5.2 DEGREES REMARK 500 ARG A 204 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ASP A 220 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ARG A 264 NE - CZ - NH1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ARG A 264 NE - CZ - NH2 ANGL. DEV. = -6.2 DEGREES REMARK 500 TYR A 347 CB - CG - CD1 ANGL. DEV. = 4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 178 -54.51 -120.77 REMARK 500 TYR A 224 16.12 -159.77 REMARK 500 ASN A 344 41.97 -104.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WY4 A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 410 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 411 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 412 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 413 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GCE RELATED DB: PDB REMARK 900 BETA-LACTAMASE (UNLIGANDED) OF ENTEROBACTER CLOACAE GC1 REMARK 900 RELATED ID: 1GAO RELATED DB: PDB REMARK 900 GC1 BETA-LACTAMASE WITH A SULFONE INHIBITOR REMARK 900 RELATED ID: 1ONG RELATED DB: PDB REMARK 900 SHV-1 BETA-LACTAMASE WITH A PENEM INHIBITOR DBREF 1ONH A 1 364 UNP Q59401 Q59401_ENTCL 21 384 SEQRES 1 A 364 THR PRO VAL SER GLU LYS GLN LEU ALA GLU VAL VAL ALA SEQRES 2 A 364 ASN THR VAL THR PRO LEU MET LYS ALA GLN SER VAL PRO SEQRES 3 A 364 GLY MET ALA VAL ALA VAL ILE TYR GLN GLY LYS PRO HIS SEQRES 4 A 364 TYR TYR THR PHE GLY LYS ALA ASP ILE ALA ALA ASN LYS SEQRES 5 A 364 PRO VAL THR PRO GLN THR LEU PHE GLU LEU GLY SER ILE SEQRES 6 A 364 SER LYS THR PHE THR GLY VAL LEU GLY GLY ASP ALA ILE SEQRES 7 A 364 ALA ARG GLY GLU ILE SER LEU ASP ASP PRO VAL THR ARG SEQRES 8 A 364 TYR TRP PRO GLN LEU THR GLY LYS GLN TRP GLN GLY ILE SEQRES 9 A 364 ARG MET LEU ASP LEU ALA THR TYR THR ALA GLY GLY LEU SEQRES 10 A 364 PRO LEU GLN VAL PRO ASP GLU VAL THR ASP ASN ALA SER SEQRES 11 A 364 LEU LEU ARG PHE TYR GLN ASN TRP GLN PRO GLN TRP LYS SEQRES 12 A 364 PRO GLY THR THR ARG LEU TYR ALA ASN ALA SER ILE GLY SEQRES 13 A 364 LEU PHE GLY ALA LEU ALA VAL LYS PRO SER GLY MET PRO SEQRES 14 A 364 TYR GLU GLN ALA MET THR THR ARG VAL LEU LYS PRO LEU SEQRES 15 A 364 LYS LEU ASP HIS THR TRP ILE ASN VAL PRO LYS ALA GLU SEQRES 16 A 364 GLU ALA HIS TYR ALA TRP GLY TYR ARG ASP GLY LYS ALA SEQRES 17 A 364 VAL ARG ALA VAL ARG VAL SER PRO GLY MET LEU ASP ALA SEQRES 18 A 364 GLN ALA TYR GLY VAL LYS THR ASN VAL GLN ASP MET ALA SEQRES 19 A 364 ASN TRP VAL MET ALA ASN MET ALA PRO GLU ASN VAL ALA SEQRES 20 A 364 ASP ALA SER LEU LYS GLN GLY ILE ALA LEU ALA GLN SER SEQRES 21 A 364 ARG TYR TRP ARG ILE GLY SER MET TYR GLN GLY LEU GLY SEQRES 22 A 364 TRP GLU MET LEU ASN TRP PRO VAL GLU ALA ASN THR VAL SEQRES 23 A 364 VAL GLU GLY SER ASP SER LYS VAL ALA LEU ALA PRO LEU SEQRES 24 A 364 PRO VAL ALA GLU VAL ASN PRO PRO ALA PRO PRO VAL LYS SEQRES 25 A 364 ALA SER TRP VAL HIS LYS THR GLY SER THR GLY GLY PHE SEQRES 26 A 364 GLY SER TYR VAL ALA PHE ILE PRO GLU LYS GLN ILE GLY SEQRES 27 A 364 ILE VAL MET LEU ALA ASN THR SER TYR PRO ASN PRO ALA SEQRES 28 A 364 ARG VAL GLU ALA ALA TYR HIS ILE LEU GLU ALA LEU GLN HET WY4 A 400 21 HET GOL A 410 6 HET GOL A 411 6 HET GOL A 412 6 HET GOL A 413 6 HETNAM WY4 7-(5,6-DIHYDRO-8H-IMIDAZO[2,1-C][1,4]OXAZIN-2-YL)-6- HETNAM 2 WY4 FORMYL-2,7-DIHYDRO- [1,4]THIAZEPINE-3-CARBOXYLIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 WY4 C13 H13 N3 O4 S FORMUL 3 GOL 4(C3 H8 O3) FORMUL 7 HOH *427(H2 O) HELIX 1 1 SER A 4 GLN A 23 1 20 HELIX 2 2 ILE A 65 ARG A 80 1 16 HELIX 3 3 PRO A 88 TYR A 92 5 5 HELIX 4 4 GLY A 98 GLN A 102 5 5 HELIX 5 5 ARG A 105 TYR A 112 1 8 HELIX 6 6 ASP A 127 TRP A 138 1 12 HELIX 7 7 ALA A 151 VAL A 163 1 13 HELIX 8 8 PRO A 169 VAL A 178 1 10 HELIX 9 9 PRO A 192 TYR A 199 5 8 HELIX 10 10 LEU A 219 GLY A 225 1 7 HELIX 11 11 ASN A 229 ALA A 242 1 14 HELIX 12 12 PRO A 243 VAL A 246 5 4 HELIX 13 13 ASP A 248 GLN A 259 1 12 HELIX 14 14 GLU A 282 ASP A 291 1 10 HELIX 15 15 ASP A 291 LEU A 296 1 6 HELIX 16 16 PRO A 348 LEU A 363 1 16 SHEET 1 A10 LYS A 52 PRO A 53 0 SHEET 2 A10 LYS A 37 ASP A 47 -1 N ASP A 47 O LYS A 52 SHEET 3 A10 GLY A 27 TYR A 34 -1 N VAL A 30 O TYR A 41 SHEET 4 A10 ILE A 337 ALA A 343 -1 O LEU A 342 N ALA A 29 SHEET 5 A10 GLY A 326 ILE A 332 -1 N ALA A 330 O ILE A 339 SHEET 6 A10 SER A 314 SER A 321 -1 N VAL A 316 O PHE A 331 SHEET 7 A10 GLU A 275 ASN A 278 -1 N LEU A 277 O TRP A 315 SHEET 8 A10 MET A 268 GLN A 270 -1 N TYR A 269 O MET A 276 SHEET 9 A10 ARG A 261 ILE A 265 -1 N ILE A 265 O MET A 268 SHEET 10 A10 ALA A 302 ALA A 308 -1 O ALA A 302 N ARG A 264 SHEET 1 B 3 PHE A 60 GLU A 61 0 SHEET 2 B 3 LYS A 227 THR A 228 -1 O THR A 228 N PHE A 60 SHEET 3 B 3 THR A 187 TRP A 188 -1 N TRP A 188 O LYS A 227 SHEET 1 C 2 THR A 147 ARG A 148 0 SHEET 2 C 2 LEU A 299 PRO A 300 -1 O LEU A 299 N ARG A 148 SHEET 1 D 2 GLY A 202 ARG A 204 0 SHEET 2 D 2 LYS A 207 VAL A 209 -1 O VAL A 209 N GLY A 202 LINK OG SER A 64 C7 WY4 A 400 1555 1555 1.35 CISPEP 1 TRP A 279 PRO A 280 0 1.34 CISPEP 2 ASN A 305 PRO A 306 0 -6.94 SITE 1 AC1 13 SER A 64 LEU A 119 GLN A 120 ASN A 152 SITE 2 AC1 13 GLY A 320 SER A 321 THR A 322 GLY A 323 SITE 3 AC1 13 GOL A 413 HOH A 693 HOH A 722 HOH A 740 SITE 4 AC1 13 HOH A 871 SITE 1 AC2 7 PRO A 181 LEU A 182 ASN A 245 VAL A 246 SITE 2 AC2 7 ALA A 247 ASP A 248 HOH A 768 SITE 1 AC3 4 LYS A 293 VAL A 294 ALA A 297 HOH A 652 SITE 1 AC4 9 SER A 290 ASP A 291 SER A 292 PRO A 348 SITE 2 AC4 9 ASN A 349 PRO A 350 HOH A 663 HOH A 872 SITE 3 AC4 9 HOH A 891 SITE 1 AC5 7 ARG A 210 ALA A 211 VAL A 212 THR A 322 SITE 2 AC5 7 GLY A 323 WY4 A 400 HOH A 562 CRYST1 76.288 68.873 62.014 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013108 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014519 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016125 0.00000